Skip to content
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
×
Home
About
Who we are
Our Team
Distill EDC
Benefits
Features
Pricing
Industry News
Latest
RWE
Clinical Trials
Oncology
SVM
Case Studies
Publications
Endorsements
Pricing
Contact
PUBLICATIONS
Aztreonam Lysine (Cayston)
15 February 2022
READ MORE
Posts navigation
← Effects of Initiating or Switching to a Six-Monthly Triptorelin Formulation on Prostate Cancer Patient– Healthcare Interactions and Hospital Resource Use: a Real-World, Retrospective, Non-Interventional Study